intercept pharmaceuticals appoints rachel mcminn phd as chief strategy officer nasdaqicpt facebook google linkedin twitter email rss apr   previous release  next release pdf add to briefcase file is in briefcase intercept pharmaceuticals appoints rachel mcminn phd as chief strategy officer new york april   globe newswire  intercept pharmaceuticals inc nasdaqicpt intercept a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases today announced the appointment of rachel mcminn phd to the newly created position of chief strategy officer dr mcminn will be responsible for leading corporate strategy and business development she will report to mark pruzanski md president and ceo of intercept and will be a member of the intercept management team rachel is very highly regarded in the biotechnology sector commented dr pruzanski her scientific and financial background coupled with her experience as a leading research analyst will bring valuable strategic insight to help guide intercepts growth and future success‎ i am extremely excited to join mark and the intercept team to build a company poised to deliver important new medicines to patients suffering from diseases with high unmet needs said dr mcminn  dr mcminn brings more than  years of biotechnology industry experience to the company since  until joining intercept she was a managing director at bank of america merrill lynch working as the lead research analyst covering the biotechnology industry previously dr mcminn worked at cowen and company as a lead biotechnology analyst and started her career as a biotechnology analyst at piper jaffray  co she earned a bachelor of arts degree in chemistry from cornell university a phd in molecular and cellular biology and chemistry from the scripps research institute and was awarded a postdoctoral miller fellowship at the university of california at berkeleyabout intercept intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry the companys lead product candidate obeticholic acid oca is a bile acid analog and firstinclass agonist of the farnesoid x receptor fxr oca is being developed for a variety of chronic liver diseases including primary biliary cirrhosis pbc nonalcoholic steatohepatitis nash portal hypertension bile acid diarrhea and primary sclerosing cholangitis psc oca has met the primary efficacy endpoint in five placebocontrolled clinical trials including the recently completed poise phase  clinical trial in patients with pbc and two phase  clinical trials in nash and nonalcoholic fatty liver disease oca has received orphan drug designation in both the united states and europe for the treatment of pbc and psc intercept owns worldwide rights to oca outside of japan and china where it has outlicensed the product candidate to dainippon sumitomo pharma for more information about intercept please visit the companys website at wwwinterceptpharmacomsafe harbor statement this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements regarding intercepts plans to develop seek regulatory approvals for and commercialize oca and intercepts strategic directives under the caption about intercept these forwardlooking statements are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forwardlooking statements these risks and uncertainties include but are not limited to the success and timing of intercepts preclinical studies and clinical trials intercepts ability to obtain and maintain regulatory approval of oca and any other product candidates it may develop and the labeling under any approval it may obtain regulatory developments in the united states and other countries the performance of thirdparty manufacturers intercepts plans to develop and commercialize its product candidates intercepts ability to obtain and maintain intellectual property protection for its product candidates the successful development of intercepts sales and marketing capabilities the potential markets for intercepts product candidates and its ability to serve those markets the rate and degree of market acceptance of any future products the success of competing drugs that are or become available the loss of key scientific or management personnel intercepts ability to obtain additional financing the accuracy of intercepts estimates regarding expenses future revenues and capital requirements and other factors discussed under the heading risk factors contained in intercepts annual report on form k for the year ended  filed on march   as well as any updates to these risk factors filed from time to time in intercepts other filings with the securities and exchange commission all information in this press release is as of the date of the release and intercept undertakes no duty to update this information unless required by lawcontact for more information about intercept please contact barbara duncan or senthil sundaram both of intercept pharmaceuticals at  media inquiries mediainterceptpharmacom investor inquiries investorsinterceptpharmacom rachel mcminn  benzinga benzinga benzinga pro marketfy financial data  apis fintech awards premarket prep membership is freewhat are you waiting for sign up now username username availableusername taken email email availableemail taken password leave blank or free account login click here to access your premium account username or email password or forgot password looking for  click here contribute login sign up benzinga  feed your mind homebest of benzinga careers about contact us partners benzinga fintech awards newsearnings guidance dividends ma buybacks legal interviews management retail sales offerings ipos insider trades biotechfda marketspremarket after hours movers forex commodities options binary options bonds futures global economics previews reviews smallcap ratingsanalyst color downgrades upgrades initiations price target ideaslong ideas short ideas technicals from the press jim cramer rumors etfs techstartups fintech personal finance marketfy benzinga pro market overview tickersarticleskeywordssearch by keywordgooglecse rachel mcminn home top stories news ratings ideas options forex etfs media economics press releases latest stories store better manage your personal finances premarketbenzingacom bank of america reiterates on intercept pharmaceuticals friday january    am analyst color bank of america merrill lynch icpt rachel mcminn reiteration analyst ratings in a report published friday bank of america merrill lynch analyst rachel mcminn reiterated buy on intercept pharmaceuticals nasdaq icpt raising its price objective to  from  according to the report the price objective rise is driven by the analysts revised model which now read more  update bank of america raises po on puma biotech on ongoing studies tuesday december    am analyst color bank of america pbyi rachel mcminn price target analyst ratings in a report published tuesday bank of america analyst rachel mcminn maintained a buy rating on puma biotechnology nyse pbyi raising price target to  from  due to higher probability according to the report “pbyi hosted an investor call to provide an update on three ongoing read more  update bank of america reiterates on ariad pharmaceuticals following news of iclusig relaunch monday december    am analyst color aria bank of america rachel mcminn price target analyst ratings in a report published monday bank of america analyst rachel mcminn reiterated an underperform rating on ariad pharmaceuticals nasdaq aria and raised the price target from  to  in the report bank of america noted “aria announced on friday that it and the fda have agreed on a read more  update bank of america initiates coverage on relypsa on rare derisked late stage product story thursday december    pm analyst color bank of america rachel mcminn rlyp initiation analyst ratings in a report published thursday bank of america analyst rachel mcminn initiated coverage on relypsa nasdaq rlyp with a buy rating and  price target in the report bank of america noted “we are initiating coverage of relypsa rlyp with a buy rating and a  price objective we view read more  update bank of america increased gilead sciences pt friday november    pm analyst color bank of america merrill lynch gild rachel mcminn price target analyst ratings on friday bank of america merrill lynch analyst rachel mcminn increased the price objective for gilead sciences inc nasdaq gild from  to  mcminn expects an increase in share price as investors gain visibility on hcv pricing in late  obtain phase  data in early  observe read more  kyprolis draws focus away from amgen friday november    pm amgn analyst color bank of america merrill lynch celg rachel mcminn rbc analyst ratings bank of america merrill lynch biotech analyst rachel mcminn commented on how an increased focus on kyprolis cardiovascular toxicities among centers have stolen the spotlight from amgen nasdaq amgn rbc reported on wednesday that amgens pcsk inhibitor has a  percent probability that the read more  update bank of america downgrades ariad pharmaceuticals on uncertain iclusig outlook thursday october    am analyst color aria bank of america rachel mcminn downgrades analyst ratings in a report published thursday bank of america analyst rachel mcminn downgraded the rating on ariad pharmaceuticals nasdaq aria from buy to neutral and lowered the price target from  to  in the report bank of america noted “we rate aria a neutral based on our view that read more  update bank of america downgrades achillion pharmaceuticals following extremely negative pipeline update monday september    am achn analyst color bank of america rachel mcminn downgrades analyst ratings in a report published monday bank of america analyst rachel mcminn downgraded the rating on achillion pharmaceuticals nasdaq achn from buy to underperform and lowered the price target from  to  in the report bank of america noted “after the market close achn provided an update read more  update bank of america downgrades viropharma on valuation wednesday september    am analyst color bank of america rachel mcminn vphm downgrades analyst ratings in a report published wednesday bank of america analyst rachel mcminn downgraded the rating on viropharma nasdaq vphm from neutral to underperform but reiterated the  price target in the report bank of america noted “vphm shares have increased  in response to a media article read more  update bank of america raises pt on incyte on compelling new data wednesday august    am analyst color bank of america incy rachel mcminn price target analyst ratings in a report published wednesday bank of america analyst rachel mcminn reiterated a buy rating on incyte corporation nasdaq incy and raised the price target from  to  in the report bank of america noted “incy announced topline phase  results for its marketed jak inhibitor read more  next › newsletter  alerts become a wallstreet wizard market in  minutes everything you need to know about the market  quick  easy daily analyst rating a summary of each day’s top rating changes from sellside analysts on the street fintech focus yesterday’s biggest gainers and losers as well as  stocks to keep an eye on for today terms  conditions thank you for registering for benzinga’s newsletters and alerts • the daily analysts ratings email will be received daily between am and am • the market in  minutes email will be received daily between am and am • the fintech focus email will be received every friday between pm and pm if you have any questions as it relates to either of the three newsletters please feel free to contact us at zing trending recent  etrm cgen  stocks moving in tuesdays premarket session  cnc utx earnings scheduled for july    nvax is there life left in the novavax clinical program  goog googl impact of alphabets  billion european  amd citi still selling amd concerned about prof  amd amds big run continues with q earn  tanh lpl  stocks moving in wednesday  wwe pcln mayweathermcgregor is the most expensive combat sport event tracked by  googl fb why are some investors betting against facebook ahead of earnings  hinky michigans shorts brewing company sells  st  wynn wynn resorts sharply lower despite q beat  knd akam  biggest midday losers for wednesday  amzn cvx twitter to report q earnings what  bax blk highlights from third point benzinga is a fastgrowing dynamic and innovative financial media outlet that empowers investors with highquality unique content popular channelsanalyst ratings be your own boss etfs economics forex hot news options press releases startups tech tools  featuresaffiliate program premarket prep feeds news widget real time feed sitemap submit news tips about benzingaabout us licensing and apis apps ios and android fintech awards blog syndication in the news careers service status contact us disclaimer privacy policy terms and conditions benzinga partners    zing  copyright benzinga icpt rachel l mcminn insider trades for intercept pharmaceuticals inc x tweet share this bulletin get news bulletins by email bulletin whole foods shares edge upward after surprise midday earnings release » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close intercept pharmaceuticals inc nasdaq icpt go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus intercept pharmaceuticals inc market open  real time quotes jul    pm icpt quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual rachel l mcminn dr rachel l mcminn is chief business  strategy officer at intercept pharmaceuticals inc dr mcminn was previously employed as a principal by banc of america securities llc an analyst by merrill lynch pierce fenner  smith inc a senior analyst by piper jaffray  co broker and an analyst by piper jaffray  co she also served on the board at cowen  co llc she received his undergraduate degree from cornell university and a doctorate degree from the scripps research institute transactions date shares transaction value     disposition at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      disposition at  per share      award at  per share      disposition at  per share      disposition at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr mark e pruzanski president chief executive officer  director mr jerome b durso chief operating officer mr sandip s kapadia chief financial officer dr david a shapiro chief medical officer  executive vpdevelopment mr richard kim senior vice presidentcommercial head of us dr juan carlos lopeztalavera senior vice presidenthead medical affairs ms lisa bright presidentinternational dr rachel l mcminn chief business  strategy officer mr christopher frates media contact dr mark j vignola directorinvestor relations mr paolo fundarò chairman dr keith m gottesdiener independent director mr daniel mark bradbury independent director mr daniel g welch independent director mr gino santini independent director dr luca benatti independent director mr glenn p sblendorio independent director dr srinivas akkaraju independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwhole foods earnings beat estimates pgold settles lower for a third session ahead of the fed policy update paugust gold down  or  to settle at oz pwhole foods opened  stores including  relocation during q pwhole foods stock gains  after q results pus stocks trade in record territory ahead of fed policy decision pwhole foods q samestore sales down  factset consensus down  pwhole foods q revenue  bln vs  bln factset consensus  bln pwhole foods q adj eps  cents factset consensus  cents pwhole foods q eps  cents vs  cents a year ago pyour k match may have some strings attached pbitcoin ether on track for second straight daily decline ptake this quiz to see if you’re too sick to go to work ptwitter earnings analysts fear that last quarter’s user increase won’t be repeated pfuelcell shares halted for news pus steel surges  as betterthanexpected earnings offset trump comments pmichael kors gets a toehold in men’s shoes with jimmy choo purchase plvmhs profit climbs  in first half pcoke zero to be replaced in us market with cocacola zero sugar pthis is why it doesn’t make sense for an excongressman to shame homeless people for smartphone use loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rachel mcminn  intercept pharmaceuticals inc  zoominfocom intercept pharmaceuticals appoints rachel mcminn phd as chief strategy officer nasdaqicpt english français register sign in intercept pharmaceuticals appoints rachel mcminn phd as chief strategy officer april    et  source intercept pharmaceuticals inc new york april   globe newswire  intercept pharmaceuticals inc nasdaqicpt intercept a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver and intestinal diseases today announced the appointment of rachel mcminn phd to the newly created position of chief strategy officer dr mcminn will be responsible for leading corporate strategy and business development she will report to mark pruzanski md president and ceo of intercept and will be a member of the intercept management team rachel is very highly regarded in the biotechnology sector commented dr pruzanski her scientific and financial background coupled with her experience as a leading research analyst will bring valuable strategic insight to help guide intercepts growth and future success‎ i am extremely excited to join mark and the intercept team to build a company poised to deliver important new medicines to patients suffering from diseases with high unmet needs said dr mcminn  dr mcminn brings more than  years of biotechnology industry experience to the company since  until joining intercept she was a managing director at bank of america merrill lynch working as the lead research analyst covering the biotechnology industry previously dr mcminn worked at cowen and company as a lead biotechnology analyst and started her career as a biotechnology analyst at piper jaffray  co she earned a bachelor of arts degree in chemistry from cornell university a phd in molecular and cellular biology and chemistry from the scripps research institute and was awarded a postdoctoral miller fellowship at the university of california at berkeley about intercept intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry the companys lead product candidate obeticholic acid oca is a bile acid analog and firstinclass agonist of the farnesoid x receptor fxr oca is being developed for a variety of chronic liver diseases including primary biliary cirrhosis pbc nonalcoholic steatohepatitis nash portal hypertension bile acid diarrhea and primary sclerosing cholangitis psc oca has met the primary efficacy endpoint in five placebocontrolled clinical trials including the recently completed poise phase  clinical trial in patients with pbc and two phase  clinical trials in nash and nonalcoholic fatty liver disease oca has received orphan drug designation in both the united states and europe for the treatment of pbc and psc intercept owns worldwide rights to oca outside of japan and china where it has outlicensed the product candidate to dainippon sumitomo pharma for more information about intercept please visit the companys website at wwwinterceptpharmacom safe harbor statement this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements regarding intercepts plans to develop seek regulatory approvals for and commercialize oca and intercepts strategic directives under the caption about intercept these forwardlooking statements are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forwardlooking statements these risks and uncertainties include but are not limited to the success and timing of intercepts preclinical studies and clinical trials intercepts ability to obtain and maintain regulatory approval of oca and any other product candidates it may develop and the labeling under any approval it may obtain regulatory developments in the united states and other countries the performance of thirdparty manufacturers intercepts plans to develop and commercialize its product candidates intercepts ability to obtain and maintain intellectual property protection for its product candidates the successful development of intercepts sales and marketing capabilities the potential markets for intercepts product candidates and its ability to serve those markets the rate and degree of market acceptance of any future products the success of competing drugs that are or become available the loss of key scientific or management personnel intercepts ability to obtain additional financing the accuracy of intercepts estimates regarding expenses future revenues and capital requirements and other factors discussed under the heading risk factors contained in intercepts annual report on form k for the year ended  filed on march   as well as any updates to these risk factors filed from time to time in intercepts other filings with the securities and exchange commission all information in this press release is as of the date of the release and intercept undertakes no duty to update this information unless required by law for more information about intercept please contact barbara duncan or senthil sundaram both of intercept pharmaceuticals at  media inquiries mediainterceptpharmacom investor inquiries investorsinterceptpharmacom related articles other press releases by intercept pharmaceuticals inc intercept to report second quarter  financial results on july  july    intercept’s ocaliva® obeticholic acid receives  galien chemical synthesis drug award in italy june    intercept announces new data analysis from flint trial of oca in nash patients with type  diabetes june    health canada grants approval for ocaliva™ obeticholic acid for the treatment of patients with primary biliary cholangitis pbc may    intercept receives innovation award from the national organization for rare disorders for the development of ocaliva® obeticholic acid may     other news releases in directors and officers in the last  days profile intercept pharmaceuticals inc   subscribe via rss  subscribe via atom  javascript new york new york united states contact data for more information about intercept please contact barbara duncan or senthil sundaram both of intercept pharmaceuticals at  media inquiries mediainterceptpharmacom investor inquiries investorsinterceptpharmacom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files intercept pharmaceuticals inc logo logo url  copy the link below formats available original medium small tags biotechnology pharmaceuticals management changes newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved rachel mcminn   facebook facebook？english us한국어français francebahasa indonesiapolskiespañolportuguês brasildeutschitalianomessengerfacebook liteinstagramcookie facebook   insider trading  mcminn rachel  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  mcminn rachel select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view sale  pm intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer   direct view option award  pm na intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer   direct view option award  pm nana intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer   direct view option award  pm na intercept pharmaceuticals inc icpt mcminn rachelchief strategy officer   direct view   secformcom all rights reserved archives        wed  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft loading your search results  peoplelookercom updating data on  live please help us narrow down your search all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming im not sure please enter a full name please help us narrow down your search first name please enter first name last name please enter last name people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again people searching made easy  peoplelooker looking to find out about someone find information you may not get on google state alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming search we respect your privacy weve run over  background reports successful background reports access premium public records quickly search public records that could otherwise take you weeks or months to collect find friends relatives neighbors or even yourself comprehensive people search reports may contain names criminal records date of birth phone numbers addresses court records relatives email addresses much more names criminal records date of birth relatives email addresses phone numbers addresses court records much more the new way to find people more than a regular search engine its the quick and easy way to look people up do a deep public record search to uncover the important information youre looking for now youll never have to search someone on google again rachel mcminn  netfind content results aol search skip over navigation search the web web web content we found rachel mcminn  peoplelookercom ad · wwwpeoplelookercom  rachel mcminns phone  address  age  more search free uncover potential relatives photos  videos historical deeds location history email address monitor social info beautiful creatures  film rachel weisz as petula susan lynch as dorothy iain glen as tony tom mannion as brian mcminn maurice roëves as ronnie mcminn alex norton as detective inspector hepburn jake more go to encyclopedia  news  videos  reference source wikipedia results from the wowcom content network mcminn county tennessee  wowcom wwwwowcomwikiathenstnmicropolitanstatisticalarea mcminn county was created in  from indian lands and was  municipalities and communities of mcminn county tennessee united states county   rachel reeves rachel maddow ratings double regularly top larry kings  wwwhuffingtonpostcomrachelmaddowratingsdoun rachel maddow a woman who does not own a television set has done something that is virtually unheard of she has doubled the audience for a cable news  rachel maddow ratings beats olbermanns countdown to be  wwwhuffingtonpostcomrachelmaddowratingsbean the student has surpassed the master at least for one night the rachel maddow show was msnbcs toprated broadcast tuesday night unseating keith  aols rachel gross named top event innovator httpscorpaolcomnewsaolsrachelgrossnamedtopeventinnovator bizbash leading trade media group for the events industry just unveiled its second annual list of the  most innovative people in the business and aols rachel  top  at  rachel weiszs red carpet style  aol lifestyle httpswwwaolcomarticlelifestyletoprachel actress rachel weisz is one of those people who doesnt age the actress turns yearsold today and we are dying to know her secret rachel has been out  rachel zoe kate young top list of hollywoods most  wwwhuffingtonpostcomrachelzoekateyoungtopn rachel zoe kate young top list of hollywoods most powerful stylists photos poll  rachel zoe  who dressed hathaway on oscar night  athens tennessee  wowcom wwwwowcomwikiathenstn athens was laid out and chosen as the county seat in   mcminn county memphis tenn   rachel reeves give feedback rachel maddow republicans got shellacked on election  wwwhuffingtonpostcomrachelmaddowrepublicans rachel maddow relished all the democratic wins from tuesday nights election before launching into a long list of accomplishments maddow told her vi rachel dolezal responds to ethnicity questions yes i do  wwwhuffingtonpostcomracheldolezalblacknhtml naacp leader rachel dolezal had choice words friday for those questioning her ethnicity niota tennessee  wowcom wwwwowcomwikiniotatennessee wikimedia commons has media related to niota tennessee  municipalities and communities of mcminn county tennessee united states   rachel reeves we found rachel mcminn  peoplelookercom ad · wwwpeoplelookercom  rachel mcminns phone  address  age  more search free uncover potential relatives photos  videos historical deeds location history email address monitor social info searches related torachel mcminn rachel mcminn ct rachel mcminn intercept rachel mcminn intercept pharmaceuticals rachel mcminn christopher swirchak the other side of loneliness next related searches rachel mcminn ct rachel mcminn intercept rachel mcminn intercept pharmaceuticals rachel mcminn christopher swirchak the other side of loneliness search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network